Prodrugs Assemble
February 28, 2022
How in vivo synthesis of anticancer drugs could be the hero we need
1 min read

February 28, 2022
How in vivo synthesis of anticancer drugs could be the hero we need
1 min read
February 25, 2022
How challenges in ophthalmic drug delivery could be overcome by nanotechnology
1 min read
February 25, 2022
How an RNA targeting approach helped patients living with spinal muscular atrophy
1 min read
February 24, 2022
In this new article series, we ask industry leaders to answer one key question
1 min read
February 23, 2022
As the US opioid crisis continues, there is now significant interest in non-addictive painkillers
1 min read
February 22, 2022
Fear of the unknown has made pharma companies reluctant to use novel excipients. And excipient manufacturers – due to uncertainty in realizing business benefits in developing new excipients for pharma are reluctant to make significant investments The result? Limited innovation in novel excipients to support the new drug modalities coming through industry pipelines – and less than optimized drug formulations reaching patients..
1 min read
February 21, 2022
mRNA has become a superstar thanks to the success of mRNA-based COVID-19 vaccines, but its importance was known long before the pandemic. Bellal Moghis from the Diagnostics and Genomics Group at Agilent Technologies tells us about the potential of mRNA – and the challenges of working with and analyzing mRNA.
1 min read
February 18, 2022
We sit down to interview Louise Modis, Chief Scientific Officer at Mogrify, UK, about her career and role at the company.
1 min read
February 18, 2022
With so many new dosage forms and breakthroughs being seen in the pharma industry, a problem is emerging: the need for unique formulation solutions – and novel excipients. In fact, the industry has needed novel excipients for years…
1 min read
February 17, 2022
How MilliporeSigma and SaudiVax are working together to help patients in the Middle East and North Africa access the benefits of advanced medicine
1 min read
False
False